Quantitative determination of piroxicam in a new formulation (piroxicam-β-cyclodextrin) by derivative UV spectrophotometric method and HPLC

被引:46
作者
Basan, H [1 ]
Göger, NG [1 ]
Ertas, N [1 ]
Orbey, MT [1 ]
机构
[1] Gazi Univ, Fac Pharm, Dept Analyt Chem, TR-06330 Ankara, Turkey
关键词
piroxicam; beta-cyclodextrin; derivative UV spectrophotometry; reversed-phase HPLC;
D O I
10.1016/S0731-7085(01)00383-1
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A derivative ultraviolet (UV) spectrophotometric method for the determination of piroxicam in piroxicam-p-cyclodextrin tablets was developed. Phosphate buffer (pH 7.8, .0.1 M) and ethanol were used as a solvent system throughout the study. ln this study, determination of piroxicam was conducted by using first order derivative amplitudes at 261.4 nm (n = 4). Standards for the calibration graph ranging from 2.40 to 20.0 mug/ml were prepared from working standard. The proposed method is accurate with 99.70% +/- 0.50 recovery value and precise with coefficient of variation (CV) of 1.29 The results were compared with those obtained using a high-performance liquid chromatography (HPLC) procedure. A reversed-phase C-18 column with aqueous phosphate buffer:methanol, 60:40, v/v, mobile phase was used. UV detector was set at 254 nm. Calibration solutions used in HPLC were ranging from 5 to 20 mug/ml. Results obtained in HPLC were comparable to those obtained by derivative UV spectrophotometric method. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 23 条
  • [1] AGRAWAL Y K, 1989, Indian Journal of Pharmaceutical Sciences, V51, P203
  • [2] Atay O, 1997, SCI PHARM, V65, P131
  • [3] QUANTITATIVE-ANALYSIS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS BY CAPILLARY ZONE ELECTROPHORESIS
    BECHET, I
    FILLET, M
    HUBERT, P
    CROMMEN, J
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (4-5) : 497 - 503
  • [4] DETERMINATION OF 2-AMINOPYRIDINE IN PIROXICAM BY DERIVATIVE UV-SPECTROPHOTOMETRY
    CARLUCCI, G
    COLANZI, A
    MAZZEO, P
    QUAGLIA, MG
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 53 (03) : 257 - 259
  • [5] CHOWDARY KPR, 1988, INDIAN DRUGS, V26, P89
  • [6] DU M, 1986, YAOXUE TONGBAO, V21, P345
  • [7] ANALYSIS OF SOME DOSAGE FORMS CONTAINING PYRIDINE-DERIVATIVES USING A CYCLODEXTRIN BONDED STATIONARY PHASE IN HPLC
    ELGEZAWI, S
    OMAR, N
    ELRABBAT, N
    PERRIN, JH
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1988, 6 (04) : 393 - 398
  • [8] Spectrofluorimetric determination of piroxicam in the presence and absence of β-cyclodextrin
    Escandar, GM
    [J]. ANALYST, 1999, 124 (04) : 587 - 591
  • [9] APPLICATION OF PROTON MAGNETIC-RESONANCE SPECTROMETRY IN THE ANALYSIS OF PIROXICAM AND ITS PHARMACEUTICAL FORMULATIONS
    FATTAH, SAA
    ELKHATEEB, SZ
    RAZEG, SAA
    STAWAKKOL, MS
    [J]. SPECTROSCOPY LETTERS, 1988, 21 (05) : 421 - 427
  • [10] Ge S D, 1988, Yao Xue Xue Bao, V23, P38